How many years of comparable data are there for Heavily indebted poor countries (HIPC) and Turkey?

6 years are reported by both, from 2000 to 2021.

Where does this data come from?

Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Heavily indebted poor countries (HIPC) vs Turkey: Cause of death, by non-communicable diseases, ages 5-14

Heavily indebted poor countries (HIPC)

20.4%

in 2021

Turkey

56.0%

in 2021

Heavily indebted poor countries (HIPC) rank

41st

Turkey rank

43rd

Cause of death, by non-communicable diseases, ages 5-14 over time

Heavily indebted poor countries (HIPC)
Turkey

How they compare

Turkey currently reports 56.0% against 20.4% in Heavily indebted poor countries (HIPC), a difference of 35.6%.

That makes Turkey's figure about 2.7 times Heavily indebted poor countries (HIPC)'s.

Across all 6 years both countries report, Turkey has been ahead every year.

Heavily indebted poor countries (HIPC) ranks 41st and Turkey ranks 43rd of 47 groups.

Turkey has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Heavily indebted poor countries (HIPC)	Turkey	Difference	Ahead
2000s	13.1%	47.1%	34.0%	Turkey
2010s	17.8%	56.5%	38.6%	Turkey
2020s	20.6%	56.2%	35.7%	Turkey

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, ages 5-14, Heavily indebted poor countries (HIPC) or Turkey?: Turkey, at 56.0% against 20.4% in Heavily indebted poor countries (HIPC) as of 2021.
What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Heavily indebted poor countries (HIPC) and Turkey?: 35.6%, with Turkey ahead.
How many years of comparable data are there for Heavily indebted poor countries (HIPC) and Turkey?: 6 years are reported by both, from 2000 to 2021.
How do Heavily indebted poor countries (HIPC) and Turkey rank globally for cause of death, by non-communicable diseases, ages 5-14?: Heavily indebted poor countries (HIPC) ranks 41st and Turkey ranks 43rd of 47 groups.
Where does this data come from?: Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Heavily indebted poor countries (HIPC) vs Turkey: Cause of death, by non-communicable diseases, ages 5-14. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-5-14-percent-of-total-deaths-ages-5-14/heavily-indebted-poor-countries-hipc/turkiye/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-5-14-percent-of-total-deaths-ages-5-14/heavily-indebted-poor-countries-hipc/turkiye/">Heavily indebted poor countries (HIPC) vs Turkey: Cause of death, by non-communicable diseases, ages 5-14</a> — Statizoid

About this data

Indicator: Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14)
Unit: % of total deaths ages 5-14
Source: Global Health Estimates, World Health Organization (WHO)
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 232 places, 1,392 data points, 2000–2021
Last refreshed: 18 September 2026

Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.